Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 1/20 | 0.49 |
| ▸ | SCN9A | Q15858 | 6/20 | 0.43 |
| ▸ | ALPL | P05186 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | ACLY | P53396 | 2/20 | 0.41 |
| ▸ | KAT6A | Q92794 | 5/20 | 0.39 |
| ▸ | KAT7 | O95251 | 4/20 | 0.39 |
| ▸ | KAT6B | Q8WYB5 | 3/20 | 0.39 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.38 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23635883 | 0.84 | KDM4E (0.50) | TP53KAT6AKAT7KAT6BKAT5 | |
| SCHEMBL23631827 | 0.84 | ALDH1A1 (0.51) | TP53MAPT | |
| SCHEMBL23635956 | 0.84 | MAPT (0.47) | NR3C2SCN9ATP53KAT6AKAT7 | |
| SCHEMBL23631813 | 0.84 | KMT2A (0.47) | ALPLKAT6AKAT7KAT6BKAT5 | |
| SCHEMBL23292514 | 0.82 | TSHR (0.46) | SCN9AALPLACLYKAT6AKAT7 | |
| SCHEMBL23631795 | 0.81 | KAT7 (0.43) | TP53KAT6AKAT7KAT6BKAT5 | |
| SCHEMBL27097779 | 0.81 | MAPT (0.48) | SCN9AALPLMAPT | |
| SCHEMBL23631841 | 0.81 | RAB9A (0.46) | ALPLTP53ACLYKAT6AMAPT | |
| SCHEMBL23635893 | 0.80 | SCN9A (0.42) | SCN9AKAT6AKAT7KAT6BKAT5 | |
| SCHEMBL23635968 | 0.77 | STAT3 (0.50) | KAT6AKAT7KAT6BKAT5KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240277683-A1 | COMPOUNDS | CTXT PTY LTD (AU) | 2024-08-22 | — | — | US | disclosed |
| US-11911372-B2 | Compounds | CTXT PTY LTD (AU) | 2024-02-27 | — | — | US | disclosed |
| US-11911372-B2 | Compounds | CTXT PTY LTD (AU) | 2024-02-27 | — | — | US | disclosed |
| US-11911372-B2 | Compounds | CTXT PTY LTD (AU) | 2024-02-27 | — | — | US | disclosed |
| US-20210213004-A1 | Compounds | CTXT PTY LTD (AU) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240277683-A1 | COMPOUNDS | SLC10A1, ABCB11, REN | NR3C2 69/4885SCN9A 172/4885ALPL 953/4885 |
| US-20210213004-A1 | Compounds | SLC10A1, ABCB11, REN | NR3C2 72/4885SCN9A 163/4885ALPL 1275/4885 |
| US-11911372-B2 | Compounds | SLC10A1, ABCB11, REN | NR3C2 72/4885SCN9A 163/4885ALPL 1275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.